Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Organ Procurement Reform topic
No spam. Unsubscribe anytime.
HHS announces unprecedented mid‑cycle decertification of Miami organ procurement organization, unveils systemwide reforms
Summary
The U.S. Department of Health and Human Services announced it will terminate the Medicare participation agreement for Life Alliance Organ Recovery Agency in Miami, citing years of patient‑safety and data failures, and outlined enforcement, transparency and donation‑support measures including a $25 million living‑donor reimbursement program.
The U.S. Department of Health and Human Services announced Friday that it will decertify Life Alliance Organ Recovery Agency, the organ procurement organization (OPO) serving parts of South Florida, and terminate that OPO's Medicare participation agreement after years of documented patient‑safety and data failures.
Secretary Kennedy said the agency consistently fell short of federal requirements and staffing standards, including what he described as “a 65% staffing shortage consistently across the years” that may have caused “as many as 8 missed organ recoveries each week, roughly 1 life lost each day.” The secretary said the move is the first mid‑cycle decertification of an OPO in federal history.
The announcement also outlined a suite of reforms intended to strengthen oversight, transparency and donor support across the nationwide organ procurement and transplantation system. Officials from the Centers for Medicare & Medicaid Services (CMS), the Health Resources and Services Administration (HRSA) and other HHS components described stepped‑up enforcement of Medicare requirements, new reporting tools for allocation irregularities, a permanent patient safety officer for the Organ Procurement and Transplantation Network (OPTN) and investments to increase organ availability.
Why it matters: Nearly 100,000 people are on the transplant wait list, officials said, and an estimated 28,000 organs are discarded annually. HHS officials framed the decertification and related measures as necessary to restore public trust, reduce avoidable organ loss and improve fairness in allocation.
Details of the decision and oversight changes Secretary Kennedy told reporters the decision follows years of “documented patient safety data failures and repeated violations of federal requirements.” He said CMS will terminate the Miami OPO's Medicare participation agreement, an action he characterized as a warning to other OPOs that fail to meet federal standards.
Tom Engels, administrator of the Health Resources and Services Administration, described HRSA's recent work to modernize OPTN governance and monitoring. He said HRSA has separated OPTN governance from its long‑term contractor, seeded a new independent board by election, launched a public dashboard to flag allocation decisions that deviate from policy and opened a direct reporting channel for misconduct and safety concerns.
Enforcement and continuity HHS officials said the Miami OPO may appeal the decertification to the HHS secretary; the appeal process will take several months and, if the decertification is sustained, HHS will open the service area to other OPOs or new entrants. Secretary Kennedy said HHS expects coverage for patients in the region to remain “seamless” during the transition and praised other OPOs that are meeting standards.
Support for donors and long‑term innovations Deputy and agency speakers announced immediate and longer‑term investments to increase available organs. HHS committed $25 million to HRSA's living organ donation reimbursement program to reduce nonmedical expenses for living donors, including lost wages, travel, lodging, meals and independent care, officials said. HHS also highlighted support for KidneyX innovation, Food and Drug Administration–approved xenotransplant clinical trials for genetically modified pig organs and ARPA‑H investments in bioprinting and regenerative medicine to develop future alternatives to human donor organs.
Investigations and fraud allegations When asked about allegations of double billing and Medicare fraud at some OPOs, officials said investigations are under way. Secretary Kennedy said the department is investigating billing allegations “very seriously” but that billing is not the primary concern motivating the decertification action described at the event.
Process and next steps Officials described the decertification as an administrative termination of the Medicare participation agreement, subject to the OPO's right to appeal. HHS said it will continue to monitor other OPOs, enforce CMS conditions of participation, and press OPTN to implement policy changes and safety reporting mechanisms. The department said further corrective actions and oversight measures are likely.
Ending note Officials framed the day as the start of a broader safety and transparency effort intended to restore public confidence in organ donation and transplantation.
